Elkhorn Partners’s CVS Health CVS Stock Holding History

Elkhorn Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-700	Closed	-$41K	–	47
2024 Q2	$41K	Buy	+700	New	+$43.8K	0.03%	40
2023 Q3	–	Sell	-100	Closed	-$7K	–	53
2023 Q2	$7K	Buy	+100	New	+$7.12K	﹤0.01%	46

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Elkhorn Partners's CVS Position: Q3 2024 in Review

Elkhorn Partners sold out of CVS Health (CVS) in Q3 2024, closing a stake of 700 shares — an estimated $41K sold.

Elkhorn Partners first reported a position in CVS in Q2 2023 and held it in 2 quarters. The position peaked at $41K in Q2 2024. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

Elkhorn Partners reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
Elkhorn Partners sold 700 CVS Health shares in Q3 2024, an estimated $41K.
Elkhorn Partners first reported a position in CVS Health in Q2 2023 and held it in 2 quarters.
Elkhorn Partners's CVS Health position peaked at $41K in Q2 2024.
1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Elkhorn Partners's 13F filing for Q3 2024, filed 13 Nov 2024.